What it's for (Indications)
- Sodium hyaluronate is primarily indicated for the treatment of pain associated with osteoarthritis (OA) in synovial joints, most commonly the knee, but also includes the hip and shoulder.
- It is typically prescribed for patients who have experienced an inadequate response to conservative non-pharmacologic therapies (such as physical therapy, exercise, and weight management) and simple analgesics (e.
- g.
- , acetaminophen or non-steroidal anti-inflammatory drugs - NSAIDs).
- This viscosupplementation therapy aims to restore the viscoelastic properties of the synovial fluid within the affected osteoarthritic joint, thereby reducing pain, improving joint lubrication, and enhancing overall physical function and mobility in carefully selected patient populations.
- Its use is considered when less invasive options have not provided sufficient relief or are contraindicated.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage regimen for sodium hyaluronate intra-articular injections varies significantly depending on the specific product formulation (e.g., molecular weight, concentration), the joint being treated, and the manufacturer's recommendations. Common regimens involve a series of injections, often weekly for 3 to 5 weeks, or a single injection of a higher concentration product. For knee OA, typical volumes range from 2 mL to 3 mL per injection. The full course of treatment may be repeated after a period, usually 6 months or more, if the patient experienced clinical benefit from the initial course and their symptoms recur. Administration must be performed by a qualified healthcare professional using strict aseptic technique to minimize the risk of infection. Patients are generally advised to avoid strenuous activities for at least 48 hours post-injection. |
Safety & Warnings
Common Side Effects
- Local reactions at the injection site are the most common adverse events and typically include transient pain, swelling, warmth, redness, stiffness, bruising, and joint effusion.
- These reactions are usually mild to moderate in severity and resolve spontaneously within a few days.
- Less commonly, patients may experience acute, severe inflammatory responses, sometimes referred to as pseudo-septic reactions, characterized by marked pain, swelling, and warmth, which can mimic septic arthritis but are sterile.
- Systemic side effects are rare due to minimal systemic absorption but can include headache, dizziness, nausea, and peripheral edema.
- Although infrequent, serious hypersensitivity reactions, including anaphylaxis, have been reported.
- There is also a potential risk of joint infection if aseptic technique is not rigorously adhered to during the injection procedure, leading to septic arthritis.
Serious Warnings
- Black Box Warning: Sodium hyaluronate injections for osteoarthritis do not carry a specific FDA-mandated Black Box Warning. However, several serious warnings and precautions are crucial for safe and effective use: **Serious Warnings:** * **Risk of Joint Infection (Septic Arthritis):** Intra-articular injection, by its nature, carries an inherent risk of introducing infection into the joint, potentially leading to septic arthritis. Strict aseptic technique must be meticulously followed during the preparation and administration of the injection. Patients should be educated to recognize and report any signs of joint infection (e.g., severe or escalating pain, marked swelling, warmth, redness, fever, malaise) to their healthcare provider immediately post-injection for prompt evaluation and appropriate management. * **Pseudo-septic Reactions:** Acute, severe inflammatory reactions, sometimes referred to as pseudo-septic reactions, can occur following sodium hyaluronate injection. These sterile inflammatory responses are characterized by symptoms such as pronounced joint pain, swelling, warmth, and effusions that can mimic a true septic arthritis. While typically resolving with symptomatic treatment, careful differential diagnosis is paramount to rule out actual infection. * **Hypersensitivity Reactions:** Although rare, serious hypersensitivity reactions, including anaphylaxis, have been reported post-marketing. Healthcare facilities should be prepared to manage such events, and patients should be monitored for any signs of allergic reactions, particularly immediately following administration. * **Avoidance of Incorrect Administration:** Sodium hyaluronate is intended for intra-articular use only. It must not be injected intravascularly or extra-articularly, as this can lead to systemic adverse events or localized tissue damage, respectively. Patients should be advised to limit strenuous activities, such as jogging, prolonged standing, or heavy lifting, and refrain from weight-bearing activities on the injected joint for at least 48 hours following the injection to minimize mechanical stress and potential complications.
- Sodium hyaluronate should not be injected if there is an active infection or skin disease in the area of the injection site or within the affected joint itself, as this substantially increases the risk of septic arthritis.
- Caution must be exercised to avoid intravascular or extra-articular injection, which could lead to localized tissue damage or systemic adverse effects.
- Patients should be informed about the potential for a transient increase in joint pain, swelling, or inflammation following the injection and advised to avoid strenuous activities or excessive weight-bearing for at least 48 hours.
- Efficacy and safety have not been conclusively established in pregnant or lactating women, or in pediatric patients, necessitating a careful risk-benefit assessment in these populations.
- Patients with known hypersensitivity to hyaluronan preparations or, for avian-derived products, to avian proteins (e.
- g.
- , eggs, feathers) should not receive this treatment.
- The effectiveness of repeat courses of therapy has not been fully established for all formulations and may vary.
How it Works (Mechanism of Action)
Sodium hyaluronate is a naturally occurring polysaccharide found in the extracellular matrix of many tissues and is a major component of synovial fluid. In healthy joints, synovial fluid, rich in high molecular weight hyaluronic acid, provides lubrication, shock absorption, and nutrient transport to articular cartilage. In osteoarthritic joints, the concentration and molecular weight of endogenous hyaluronic acid in the synovial fluid are often significantly reduced, leading to diminished viscoelasticity, impaired lubrication, and increased mechanical stress on the cartilage. Exogenously administered sodium hyaluronate (viscosupplementation) aims to restore these crucial viscoelastic properties of the synovial fluid, thereby improving joint lubrication, enhancing shock absorption, and facilitating smoother joint movement. It is also believed to exert analgesic and anti-inflammatory effects by modulating nociceptive pathways, reducing inflammatory mediators, and protecting the articular cartilage surface. The exogenous hyaluronate is gradually integrated into the synovial fluid and subsequently metabolized.